Six held for exchanging bribes to give favourable report to medical colleges

The six accused were arrested when the bribe amount of ₹55 lakh was exchanging hands. The money was delivered in Bengaluru

The Central Bureau of Investigation (CBI) has arrested six persons, including three doctors, for allegedly facilitating the submission of favourable inspection reports of medical colleges in exchange for bribes.

“A case was registered against the office-bearers of Shri Rawatpura Sarkar Institute of Medical Sciences & Research, Nava Raipur, Chhattisgarh; inspecting doctors; and other intermediaries for allegedly manipulating the statutory inspection process conducted for recognition of the medical college, in return for bribes,” said the agency in a statement on Tuesday.

The designated assessors allegedly gave favourable reports to various medical colleges in exchange for illegal gratification.

Acting on information that officials of Shri Rawatpura Sarkar Institute were purportedly influencing the assessors deputed for inspection, the CBI laid a trap. The six accused were arrested when the bribe amount of ₹55 lakh was exchanging hands. The money was delivered in Bengaluru, said the agency.

Various modi operandi were used by the accused to manipulate the process by illegally influencing inspecting doctors.

“The CBI is conducting searches at more than 40 locations across Karnataka, Rajasthan, Chhattisgarh, Uttar Pradesh, Delhi, and Madhya Pradesh,” it said.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre